Canada Pension Plan Investment Board Takes Position in Chemed Corporation $CHE

Key Points

• Canada Pension Plan Investment Board initiated a Chemed position of 3,440 shares valued at approximately $1.6 million, while institutional investors collectively own 95.85% of the company.
• Chemed exceeded quarterly expectations, reporting $6.06 in EPS and $673.25 million in revenue, with revenue up 8.8% year over year. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Analysts maintain a consensus “Hold” rating with a $530.75 price target; meanwhile, insiders have sold 6,537 shares worth $3.4 million over the past 90 days, and Chemed raised its quarterly dividend to $0.70 from $0.60.

Canada Pension Plan Investment Board bought a new position in shares of Chemed Corporation (NYSE:CHE - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,440 shares of the company's stock, valued at approximately $1,602,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. grew its stake in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company's stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in Chemed by 67.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company's stock valued at $5,534,000 after buying an additional 4,560 shares in the last quarter. Marshall Wace LLP acquired a new stake in Chemed in the second quarter valued at $579,000. Brown Advisory Inc. lifted its holdings in Chemed by 36.9% during the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company's stock worth $267,000 after buying an additional 148 shares during the last quarter. Finally, Cerity Partners LLC lifted its holdings in Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company's stock worth $2,165,000 after buying an additional 3,133 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on CHE. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 1st. Oppenheimer increased their target price on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research report on Friday, July 31st. Bank of America reiterated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Royal Bank Of Canada boosted their price target on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $530.75.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the sale, the chief executive officer owned 70,418 shares in the company, valued at approximately $37,991,215.18. This trade represents a 2.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 1,000 shares of Chemed stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the sale, the executive vice president directly owned 13,912 shares in the company, valued at approximately $7,526,948.48. The trade was a 6.71% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 6,537 shares of company stock valued at $3,406,014. Corporate insiders own 3.33% of the company's stock.

Chemed Stock Down 1.0%

CHE stock opened at $518.26 on Tuesday. The company has a fifty day moving average price of $511.08 and a 200 day moving average price of $450.15. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $557.00. The company has a market cap of $6.77 billion, a price-to-earnings ratio of 26.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.

Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to analysts' expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business's revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a $0.70 dividend. This is a positive change from Chemed's previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. Chemed's payout ratio is 14.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source